By Stefan J. Bos, Chief International Correspondent Worthy News
LONDON/BUDAPEST (Worthy News) – AstraZeneca is withdrawing its controversial coronavirus vaccine, which it claims saved millions of lives but has come under criticism over cases of severe blood clotting.
The decision came months after the British-Swedish pharma giant admitted the drug could cause very rare but life-threatening injuries such as blood clots and low blood platelet counts.
The European Medicines Agency also announced the withdrawal, Worthy News observed, which means that the Vaxzevria vaccine is no longer authorized to be marketed or sold in European Union countries.
Vaxzevria, developed in partnership with the University of Oxford, was one of the primary COVID-19 vaccines worldwide, with over 3 billion doses supplied since the first was administered in Britain on January 4, 2021.
In a statement, AstraZeneca said the decision was made because there is now a variety of newer vaccines available that have been adapted to target COVID-19 variants.
This has led to a decline in demand for the AstraZeneca vaccine, which is no longer being manufactured or supplied. Last year, Vaxzevria sales totaled just $12 million.
Before that decline, “According to independent estimates, over 6.5 million lives were saved in the first year of use alone, and over 3 billion doses were supplied globally,” the firm said.
EFFORTS RECOGNIZED
“Our efforts have been recognized by governments around the world and are widely regarded as being a critical component of ending the global pandemic. We will now work with regulators and our partners to align on a clear path forward to conclude this chapter and significant contribution to the COVID-19 pandemic.”
However, AstraZeneca, known for its popular cancer drugs, entered the Covid-19 crisis with little experience developing vaccines. And the success of Vaxzevria was far from guaranteed.
Soon after the rollout began, the company came under fire from policymakers and health officials in Europe and the United States for missteps, including during clinical trials.
The firm omitted crucial information about side effects from public statements, including information about the blood clotting issue.
Production delays also strained relations with EU leaders.
In April 2021, British authorities recommended providing under 30s an alternative jab after Britain’s drugs regulator found that 79 people had suffered rare blood clots after vaccination – 19 of whom had died.
The regulator said this “was not proof.”
the jab had caused the clots, but the link was getting firmer.
LAWSUIT
Fast forward, AstraZeneca is now facing a group action lawsuit in Britain brought by law firm Leigh Day on behalf of 51 claimants due to injuries allegedly caused by Vaxzevria.
Twelve of the claimants are acting on behalf of a loved one who died following a complication allegedly caused by the vaccine-related to the blood clotting issue.
Asked about the court case, an AstraZeneca spokesperson said: “Our sympathy goes out to anyone who has lost loved ones or reported health problems… From the body of evidence in clinical trials and real-world data, the AstraZeneca-Oxford vaccine has continuously been shown to have an acceptable safety profile, and regulators around the world consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects.”
Dr Michael Head, a senior research fellow in global health at the University of Southampton in England, claimed the messenger RNA (mRNA) vaccines from Pfizer and Moderna were “essentially better products.”
However, they have also faced questions about side effects.
The newer mRNA vaccines use genetic material to instruct cells to make the coronavirus spike protein, which in turn causes the body to create antibodies to combat an actual COVID infection, experts say.
AstraZeneca’s COVID shot uses a cold virus common to chimpanzees as a viral vector to carry the spike protein from the coronavirus into cells.
The withdrawal of AstraZeneca was expected to increase pressure on governments to investigate vaccine policies.
Copyright 1999-2025 Worthy News. This article was originally published on Worthy News and was reproduced with permission.
Latest News from Worthy News
Senate Republicans on Thursday confirmed 48 of President Donald Trump’s executive branch nominees in a single vote, advancing his agenda to fill key government positions after invoking a new rules change last week.
Erika Kirk, the widow of slain born-again Christian conservative activist Charlie Kirk, has been unanimously chosen as the new chief executive officer and chair of the board of Turning Point USA (TPUSA), the influential group her husband founded to rally young Americans behind conservative Christian causes.
Authorities in Indonesia’s Central Java Province have halted construction of a church and related tourism compound after pressure from local council members and Muslim groups amid rising anti-Christian incidents in the world’s largest Muslim-majority nation, sources confirmed Thursday.
A young Christian man is hiding in Pakistan after being falsely accused of making “blasphemous” comments against Islam, an offence that potentially carries the death penalty under the Islamic nation’s strict blasphemy legislation, Worthy News learned Thursday.
France was gripped by a second wave of nationwide strikes on Thursday, as hundreds of thousands marched against austerity measures and looming budget cuts—unrest that not only deepens the political crisis for President Emmanuel Macron and his new prime minister, Sébastien Lecornu, but also unfolds in a season many prophecy watchers view as charged with significance.
The Israel Defense Forces (IDF) launched a broad wave of strikes Thursday evening against Hezbollah military sites in southern Lebanon, escalating its campaign against the Iranian-backed terror group’s Radwan Force.
Three Israeli divisions continued a steady push into Gaza City on Thursday, the third day of Operation Gideon’s Chariots II, as the Israel Defense Forces (IDF) seek to seize Hamas’ last stronghold in the enclave.